| Minami Kurose, OD | |
|
2910 District Ave Ste 160, Fairfax, VA 22031-2284 | |
| (703) 269-9866 | |
| (703) 269-9865 |
| Full Name | Minami Kurose |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 7 Years |
| Location | 2910 District Ave Ste 160, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134624240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 046011167 (Illinois) | Secondary |
| 152W00000X | Optometrist | 0618003062 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Myeyedr Optometry Of Virginia, Pllc | 0143448456 | 69 |
| My Eye Dr. Optometrists, Llc | 4183659238 | 7 |
| Vienna Optometry, Llc | 7810073863 | 5 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Fairfax Optometry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275699712 PECOS PAC ID: 2961434253 Enrollment ID: O20050907001192 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | My Eye Dr. Optometrists, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356406581 PECOS PAC ID: 4183659238 Enrollment ID: O20050928000482 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Miller Eyecare Reston, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891850038 PECOS PAC ID: 5890898969 Enrollment ID: O20070309000216 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Clarendon Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497810436 PECOS PAC ID: 5092804286 Enrollment ID: O20071211000732 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Vienna Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548325558 PECOS PAC ID: 7810073863 Enrollment ID: O20080401000070 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Alexandria Optometry, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376608380 PECOS PAC ID: 7012078306 Enrollment ID: O20081204000764 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Centreville Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306037734 PECOS PAC ID: 6507928751 Enrollment ID: O20081222000433 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Falls Church Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235400805 PECOS PAC ID: 0648436915 Enrollment ID: O20120801000178 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Merrifield Optometry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023353356 PECOS PAC ID: 8527211796 Enrollment ID: O20130122000221 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Pentagon City Optometry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205149820 PECOS PAC ID: 9931344801 Enrollment ID: O20130325000315 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Provider Name | Myeyedr Optometry Of Virginia, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710343744 PECOS PAC ID: 0143448456 Enrollment ID: O20160217001559 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Minami Kurose, OD 1950 Old Gallows Rd Ste 520, Vienna, VA 22182-3970 Ph: () - | Minami Kurose, OD 2910 District Ave Ste 160, Fairfax, VA 22031-2284 Ph: (703) 269-9866 |
News Archive
According to a new study conducted for the National Association of Vision Care Plans by an independent research firm, health care consumers who participate in full service, stand-alone vision insurance plans are two times (33.3 percent) more likely to receive an annual comprehensive eye examination than those consumers that have vision care coverage "bundled" with their major medical plan (16.3 percent).
Researchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.
The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.
Results of a clinical trial released in STEM CELLS Translational Medicine provide evidence that treating patients with an injection of bone marrow cells may lead to a reduction in brain injury after a stroke.
IRIDEX Corporation today announced the receipt of an Issue Notification from the U.S. Patent and Trademark Office for U.S. Patent No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent applies to a number of consumable medical devices already in the IRIDEX product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser handpieces.
› Verified 3 days ago
Dean A. Wright O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9665 Main St, Fairfax, VA 22031 Phone: 703-978-2020 Fax: 703-978-6454 | |
Myeyedr Optometrist Medicare: Medicare Enrolled Practice Location: 2910 District Ave, Suite 160, Fairfax, VA 22031 Phone: 703-369-9866 Fax: 703-269-9865 | |
Dr. Wa-lee L Courtney, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12255 Fair Lakes Parkway, Fairfax, VA 22033 Phone: 703-934-5905 Fax: 703-934-5778 | |
Maya Murray, OD Optometrist Medicare: Medicare Enrolled Practice Location: 10690 Fairfax Blvd, Fairfax, VA 22030 Phone: 703-273-6323 | |
Manmeet Chatha, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3903 Fair Ridge Dr Unit E, Fairfax, VA 22033 Phone: 703-961-9119 Fax: 312-277-3735 | |
Dr. David L Meinert, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12255 Fair Lakes Parkway, Fairfax, VA 22033 Phone: 703-934-5905 Fax: 703-934-5778 | |
Jonathan Kim, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11903-i Lee Jackson Memorial Hwy. #g133, Fairfax, VA 22033 Phone: 703-218-8036 Fax: 703-218-9841 |